Literature DB >> 6508337

Malignant hyperpyrexia.

F R Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6508337      PMCID： PMC1628819          DOI： 10.1136/adc.59.11.1013

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

Review 1.  Malignant hyperthermia: a statistical review.

Authors:  B A Britt; W Kalow
Journal:  Can Anaesth Soc J       Date:  1970-07

2.  Malignant hyperpyrexia caused by trimeprazine. Case report.

Authors:  D G Moyes
Journal:  Br J Anaesth       Date:  1973-11       Impact factor: 9.166

3.  The caffeine test of isolated human muscle in relation to malignant hyperthermia.

Authors:  W Kalow; B A Britt; A Richter
Journal:  Can Anaesth Soc J       Date:  1977-11

4.  Malignant hyperpyrexia and sudden infant death.

Authors:  M A Denborough; G J Galloway; K C Hopkinson
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

5.  Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized.

Authors:  P J Halsall; P A Cain; F R Ellis
Journal:  Br J Anaesth       Date:  1979-10       Impact factor: 9.166

Review 6.  Malignant hyperthermia.

Authors:  G A Gronert
Journal:  Anesthesiology       Date:  1980-11       Impact factor: 7.892
  6 in total
  1 in total

1.  Potential for Further Mismanagement of Fever During COVID-19 Pandemic: Possible Causes and Impacts.

Authors:  Samer Singh; Dhiraj Kishore; Rakesh K Singh
Journal:  Front Med (Lausanne)       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.